期刊文献+

胺碘酮治疗阵发性房颤的临床观察 被引量:8

下载PDF
导出
摘要 目的观察胺碘酮治疗阵发性房颤的疗效。方法选择心房颤动患者71例,在常规治疗原发病基础上,静脉注射胺碘酮负荷量150 mg,再以1 mg/min静点48 h,初次负荷量效果不满意者30 min后再静注150 mg,24 h总量〈1 200 mg。同时给予口服胺碘酮0.2 g,3次/d。5~7 d后改为0.2 g,2次/d。5~7 d后改为0.2 g,1次/d维持。对房颤持续时间〈48 h者,给予皮下注射低分子肝素钠1 mg/kg,每12 h 1次,应用3~7 d。房颤持续时间〉48 h者,同时另外增加华法令抗凝。结果本组患者显效65例(91.5%),有效5例(7%),无效1例。静脉注射胺碘酮过程中,出现注射部位局部皮肤红肿7例,血压下降4例,转复为窦性心律后出现窦性心动过缓3例。随访期间出现窦缓和慢房颤8例,1例出现肝功能异常,2例出现甲状腺激素水平升高。结论心电、血压监测下应用胺碘酮治疗阵发性房颤安全、有效,不良反应发生率低,值得临床推广。
作者 倪锦辉
出处 《实用药物与临床》 CAS 2008年第3期153-155,共3页 Practical Pharmacy and Clinical Remedies
  • 相关文献

参考文献8

  • 1何华,马长生.胺碘酮在心房颤动治疗中的研究进展[J].心血管病学进展,2007,28(6):849-853. 被引量:24
  • 2Sopher SM, Carom AJ. Atrial fibrillation., maintenance of sinus rhythm versus rate control[J]. Am J Cardiol, 1996, 77 : 24A- 37A.
  • 3Allessie MA, Konings K, Kirchhof CJ, et al. Electrophysiologic mechanisms of perpetuation of atrial fibrillation [J]. Am J Cardiol, 1996, 77(8) : 10A-23A.
  • 4Peter GD, Todd AC, Marily JW, et al. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm[J]. JACC, 1998, 31 (5) :588-592.
  • 5吴宁.心房颤动复律后抗心律失常药物应用[J].中华心律失常学杂志,2000,4(1):46-49. 被引量:22
  • 6George EK, Nikos El, Marios CS, et al. Efficacy of amiodarone for the termination of persistent atrial fibrillation [J]. American Journal of Cardiology, 1999, 83(3) :58.
  • 7Kerin NZ, Faitel K, Naini M. The efficacy of intraverous amiodarone for the conversion of chronic atrial fibrillation [J]. Archives of Internal Medicine, 1996, 156(4):49-53.
  • 8Howard PA. Guidelines for stroke prevention in patients with at rial fibrillation[J]. Drugs, 1999, 58 (3) : 997-1009.

二级参考文献57

  • 11,Coplen SE,Antman EM,Berlin JA,etal.Efficacy and safety of quinidine therapy for maintenance of sinus rhythm aftercardioversion.A meta-analysis of radomized controlled trials.Circulation,1990,82∶1106-1116.
  • 22,Reinmold SC,Cantillon CO,Friedman PL,et al.Propafenone versus sotalol for suppressionof recurrent symptomatic atrial fibrillation.Am J Cardiol,1993,71∶558-563.
  • 33,Falk RH.Flecainide-induced ventricular tachycardia and fibrillation in patientstreated for atrial fibrillation.Ann Intern Med,1989,111∶107-111.
  • 44,De Simorie A,Stabile G,Vital DF,et al.Pretreatment with verapamil in patients withpersistent or chronic atrial fibrillation who underwent electrical conversion.J Am CollCardiol,1999,34∶810-815.
  • 55,Blevins RD,Kerin NZ,Benaderet D,et al.Amiodarone in the management of refractoryatrial fibrillation.Arch Intern Med,1987,147∶1401-1404.
  • 66,Brodsky MA,Allen BJ,Walker CJ,et al.Amiodarone for maintenance of sinus rhythm afterconversion of atrial fibrillation in the setting of a dilated left atrium.Am JCardiol,1987,60∶572-575.
  • 77,Gosselink ATM,Crijns HJGM,van Gelder IC,et al.Low-dose amiodarone for maintenance ofsinus rhythm after cardioversion of atrial fibrillation or flutter.JAMA,1992,267∶3289-3293.
  • 88,Chun SH,Sager PT,Stevenson WG,et al.Long-term efficacy of amiodarone for themaintenance of normal sinus rhythm in patients with refractory atrial fibrillation orflutter.Am J Cardiol,1995,76∶47-50.
  • 99,Gold RL,Haffajee CI,Charos G,et al.Amiodarone for refractory atrial fibrillation.Am JCardiol,1986,57∶124-127.
  • 1010,Hohnloser SH,Klingenheben T,Singh BN.Amiodarone-associated proarrhythmic effects.Areview with special reference to torsade de pointes tachycardia.Ann Intern Med,1994,121∶529-535.

共引文献44

同被引文献40

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部